OTC Pharmaceuticals - Germany

  • Germany
  • In Germany, the revenue in the OTC Pharmaceuticals market is projected to reach US$10.29bn by 2024.
  • With an annual growth rate of 2.79% (CAGR 2024-2029), the market is expected to expand steadily.
  • Among the various markets within the market, the largest market share is held by Other OTC Pharmaceuticals, which is estimated to have a market volume of US$4.35bn in 2024.
  • When compared to other countries globally, the in the United States generates the highest revenue in the OTC Pharmaceuticals market, amounting to US$41,240.00m in 2024.
  • Taking into account the population figures, per person revenues in Germany reach US$123.60 in 2024.
  • Furthermore, in the OTC Pharmaceuticals market, it is projected that 14.39% of the total revenue will be generated through online sales by 2024.
  • Germany's OTC Pharmaceuticals market is experiencing a growing demand for natural and herbal remedies.

Key regions: United States, China, Germany, Japan, Europe

Region comparison

Analyst Opinion

The OTC Pharmaceuticals market in Germany has been experiencing steady growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development.Customer preferences play a significant role in the growth of the OTC Pharmaceuticals market in Germany. Consumers are increasingly seeking convenience and self-care options for minor health issues. They prefer to have easy access to over-the-counter medications without the need for a prescription. This trend is driven by a desire for quick relief and a growing awareness of the effectiveness of OTC medications for common ailments.Trends in the market also contribute to the growth of the OTC Pharmaceuticals market in Germany. One prominent trend is the increasing availability of OTC medications in pharmacies and supermarkets. This accessibility makes it easier for consumers to purchase these products without the need for a doctor's visit. Additionally, there is a growing trend towards natural and herbal remedies, as consumers seek more holistic approaches to their health and wellness.Local special circumstances in Germany have also played a role in the growth of the OTC Pharmaceuticals market. The country has a well-established healthcare system with a strong emphasis on self-care and prevention. This cultural mindset encourages individuals to take responsibility for their own health and seek out OTC medications for minor ailments. Furthermore, the high level of trust in the quality and safety of OTC medications in Germany has contributed to their widespread use.Underlying macroeconomic factors have also contributed to the growth of the OTC Pharmaceuticals market in Germany. The country has a strong economy with high levels of disposable income, allowing consumers to afford OTC medications. Additionally, the aging population in Germany has led to an increased demand for OTC medications for age-related health issues. This demographic trend is expected to continue driving growth in the market.In conclusion, the OTC Pharmaceuticals market in Germany is experiencing growth due to customer preferences for convenience and self-care, trends towards accessibility and natural remedies, local special circumstances that promote self-care and prevention, and underlying macroeconomic factors such as a strong economy and an aging population. These factors combined make Germany a favorable market for OTC pharmaceuticals.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.


  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait


Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)